The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase

被引:111
|
作者
Patel, S
Wohlfeil, ER
Rademacher, DJ
Carrier, EJ
Perry, LJ
Kundu, A
Falck, JR
Nithipatikom, K
Campbell, WB
Hillard, CJ
机构
[1] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA
[3] Univ Texas, SW Med Ctr, Dept Pharmacol & Biochem, Dallas, TX 75235 USA
关键词
endocannabinoid; marijuana; win; 55212-2; 2-arachidonylglycerol; 2,6-diisopropylphenol; SR141716;
D O I
10.1038/sj.bjp.0705334
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Propofol (2,6-diisopropylphenol) is widely used as a general anesthetic and for the maintenance of long-term sedation. We have tested the hypothesis that propofol alters endocannabinoid brain content and that this effect contributes to its sedative properties. 2 A sedating dose of propofol in mice produced a significant increase in the whole-brain content of the endocannabinoid, N-arachidonylethanolamine (anandamide), when administered intraperitoneally in either Intralipid or emulphor-ethanol vehicles. 3 In vitro, propofol is a competitive inhibitor (IC50 52 muM; 95% confidence interval 31, 87) of fatty acid amide hydrolase (FAAH), which catalyzes the degradation of anandamide. Within a series of propofol analogs, the critical structural determinants of FAAH inhibition and sedation were found to overlap. Other intravenous general anesthetics, including midazolam, ketamine, etomidate, and thiopental, do not affect FAAH activity at sedative-relevant concentrations. Thiopental, however, is a noncompetitive inhibitor of FAAH at a concentration of 2 mM. 4 Pretreatment of mice with the CB1 receptor antagonist SR141716 (1 mg kg(-1), i.p.) significantly reduced the number of mice that lost their righting reflex in response to propofol. Pretreatment of mice with the CB1 receptor agonist, Win 55212-2 (1 mg kg(-1), i.p.), significantly potentiated the loss of righting reflex produced by propofol. These data indicate that CB1 receptor activity contributes to the sedative properties of propofol. 5 These data suggest that propofol activation of the endocannabinoid system, possibly via inhibition of anandamide catabolism, contributes to the sedative properties of propofol and that FAAH could be a novel target for anesthetic development.
引用
收藏
页码:1005 / 1013
页数:9
相关论文
共 11 条
  • [1] The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity
    Patel, S
    Carrier, EJ
    Ho, WSV
    Rademacher, DJ
    Cunningham, S
    Reddy, DS
    Falck, JR
    Cravatt, BF
    Hillard, CJ
    JOURNAL OF LIPID RESEARCH, 2005, 46 (02) : 342 - 349
  • [2] Propofol inhibits fatty acid amide hydrolase in a concentration-dependent manner
    Wohlfeil, ER
    Hillard, CJ
    Campbell, WB
    ANESTHESIOLOGY, 1999, 91 (3A) : U358 - U358
  • [3] Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes
    Maccarrone, M
    De Petrocellis, L
    Bari, M
    Fezza, F
    Salvati, S
    Di Marzo, V
    Finazzi-Agrò, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 393 (02) : 321 - 328
  • [4] Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in n-acylethanolamines in mouse brain
    Lin, Lin
    Metherel, Adam H.
    Jonest, Peter J.
    Bazinet, Richard P.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 (05) : 662 - 671
  • [5] Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats
    Solinas, Marcello
    Justinova, Zuzana
    Goldberg, Steven R.
    Tanda, Gianluigi
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 (02) : 408 - 419
  • [6] Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
    Di Marzo, V
    Melck, D
    Orlando, P
    Bisogno, T
    Zagoory, O
    Bifulco, M
    Vogel, Z
    De Petrocellis, L
    BIOCHEMICAL JOURNAL, 2001, 358 (358) : 249 - 255
  • [7] Synthesis, In Vitro and In Vivo Evaluation, and Radiolabeling of Aryl Anandamide Analogues as Candidate Radioligands for In Vivo Imaging of Fatty Acid Amide Hydrolase in the Brain
    Wyffels, Leonie
    Muccioli, Giulio G.
    De Bruyne, Sylvie
    Moerman, Lieselotte
    Sambre, Johan
    Lambert, Didier M.
    De Vos, Filip
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (15) : 4613 - 4622
  • [8] Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity
    Gebeh, Alpha K.
    Willets, Jonathon M.
    Bari, Monica
    Hirst, Robert A.
    Marczylo, Timothy H.
    Taylor, Anthony H.
    Maccarrone, Mauro
    Konje, Justin C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03): : 1226 - 1234
  • [9] The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models
    Caprioli, Antonio
    Coccurello, Roberto
    Rapino, Cinzia
    Di Serio, Stefano
    Di Tommaso, Monia
    Vertechy, Mario
    Vacca, Valentina
    Battista, Natalia
    Pavone, Flaminia
    Maccarrone, Mauro
    Borsini, Franco
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (01): : 188 - 195
  • [10] SYNTHESIS AND EVALUATION OF N-(4-[11C]METHOXYPHENETHYL)ARACHIDONYLAMIDE AS PET RADIOLIGAND FOR IN VIVO IMAGING OF FATTY ACID AMIDE HYDROLASE IN THE BRAIN
    Wyffels, L.
    Muccioli, G. G.
    De Bruyne, S.
    Moerman, L.
    Lambert, D. M.
    De Vos, F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S83 - S83